{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T01:43:25Z","timestamp":1784684605520,"version":"3.55.0"},"reference-count":83,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2007,4,13]],"date-time":"2007-04-13T00:00:00Z","timestamp":1176422400000},"content-version":"vor","delay-in-days":43,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovascular Drug Reviews"],"published-print":{"date-parts":[[2007,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Oleamide (<jats:italic>cis<\/jats:italic>\u20109,10\u2010octadecenoamide), a fatty acid primary amide discovered in the cerebrospinal fluid of sleep\u2010deprived cats, has a variety of actions that give it potential as a signaling molecule, although these actions have not been extensively investigated in the cardiovascular system. The synthetic pathway probably involves synthesis of oleoylglycine and then conversion to oleamide by peptidylglycine \u03b1\u2212amidating monooxygenase (PAM); breakdown of oleamide is by fatty acid amide hydrolase (FAAH). Oleamide interacts with voltage\u2010gated Na<jats:sup>+<\/jats:sup>channels and allosterically with GABA<jats:sub>A<\/jats:sub>and 5\u2010HT<jats:sub>7<\/jats:sub>receptors as well as having cannabinoid\u2010like actions. The latter have been suggested to be due to potentiation of the effects of endocannabinoids such as anandamide by inhibiting FAAH\u2010mediated hydrolysis. This might underlie an \u201centourage effect\u201d whereby co\u2010released endogenous nonagonist congeners of endocannabinoids protect the active molecule from hydrolysis by FAAH. However, oleamide has direct agonist actions at CB<jats:sub>1<\/jats:sub>cannabinoid receptors and also activates the TRPV1 vanilloid receptor. Other actions include inhibition of gap\u2010junctional communication, and this might give oleamide a role in myocardial development. Many of these actions are absent from the<jats:italic>trans<\/jats:italic>isomer of 9,10\u2010octadecenoamide. One of the most potent actions of oleamide is vasodilation. In rat small mesenteric artery the response does not involve CB<jats:sub>1<\/jats:sub>cannabinoid receptors but another pertussis toxin\u2010sensitive, G protein\u2013coupled receptor, as yet unidentified. This receptor is sensitive to rimonabant and O\u20101918, an antagonist at the putative \u201cabnormal\u2010cannabidiol\u201d or endothelial \u201canandamide\u201d receptors. Vasodilation is mediated by endothelium\u2010derived nitric oxide, endothelium\u2010dependent hyperpolarization, and also through activation of TRPV1 receptors. A physiological role for oleamide in the heart and circulation has yet to be demonstrated, as has production by cells of the cardiovascular system, but this molecule has a range of actions that could give it considerable modulatory power.<\/jats:p>","DOI":"10.1111\/j.1527-3466.2007.00004.x","type":"journal-article","created":{"date-parts":[[2010,8,16]],"date-time":"2010-08-16T10:20:02Z","timestamp":1281954002000},"page":"46-60","source":"Crossref","is-referenced-by-count":75,"title":["Oleamide: A Fatty Acid Amide Signaling Molecule in the Cardiovascular System?"],"prefix":"10.1111","volume":"25","author":[{"given":"C. Robin","family":"Hiley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pui Man","family":"Hoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,4,13]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-200006000-00007"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.60.6.1349"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(89)90278-6"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-4547(20000915)61:6<605::AID-JNR4>3.0.CO;2-U"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-199904060-00010"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(98)00392-6"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1997.7431"},{"key":"e_1_2_6_9_1","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2174\/138161280404221010152220","article-title":"Oleamide: an endogenous sleep\u2010inducing lipid and prototypical member of a new class of biological signaling molecules","volume":"4","author":"Boger DL","year":"1998","journal-title":"Curr Pharm Des"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.9.4810"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.8.4102"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.10.5044"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.2000.279.4.L623"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0952-3278(96)90100-3"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0706093"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1527-3458.2006.00091.x"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevNeurobiol.v13.i3.20"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.prostaglandins.2006.09.001"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(98)00208-1"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(94)90134-1"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1080\/02652039509374369"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0704651"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/384083a0"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.7770779"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.10473"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119677"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1470919"},{"key":"e_1_2_6_28_1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0031-6997(25)06864-4","article-title":"Cannabinoid pharmacology","volume":"38","author":"Dewey WL","year":"1986","journal-title":"Pharmacol Rev"},{"key":"e_1_2_6_29_1","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1124\/mol.55.6.1067","article-title":"Differential regulation of peptide \u03b1\u2010amidation by dexamethasone and disulfiram","volume":"55","author":"Driscoll WJ","year":"1999","journal-title":"Mol Pharmacol"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.20852"},{"key":"e_1_2_6_31_1","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0022-3565(24)29334-4","article-title":"Behavioral evidence for the interaction of oleamide with multiple neurotransmitter systems","volume":"299","author":"Fedorova I","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0705608"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0703569"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.6.2238"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1388-1981(99)00143-2"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.139.7.1785"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1006\/abio.1999.4083"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1997.69020631.x"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0706643"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.143.6.1725"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(00)01002-X"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.15.8078"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1006\/exnr.2001.7792"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm803"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi00471a006"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.103.055392"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1205187"},{"key":"e_1_2_6_48_1","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2174\/0929867306666220401153732","article-title":"The palmitoylethanolamide and oleamide enigmas: are these two fatty acid amides cannabimimetic?","volume":"6","author":"Lambert DM","year":"1999","journal-title":"Curr Med Chem"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-200112210-00056"},{"key":"e_1_2_6_50_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0701918"},{"key":"e_1_2_6_51_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0705607"},{"key":"e_1_2_6_52_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.20.9505"},{"key":"e_1_2_6_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/0005-2760(96)00002-1"},{"key":"e_1_2_6_54_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2001.00413.x"},{"key":"e_1_2_6_55_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.275.18.13484"},{"key":"e_1_2_6_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2004.03.080"},{"key":"e_1_2_6_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(95)01311-3"},{"key":"e_1_2_6_58_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20462"},{"key":"e_1_2_6_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(98)00649-9"},{"key":"e_1_2_6_60_1","doi-asserted-by":"publisher","DOI":"10.1038\/37891"},{"key":"e_1_2_6_61_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi049529p"},{"key":"e_1_2_6_62_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.20647"},{"key":"e_1_2_6_63_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200101000-00022"},{"key":"e_1_2_6_64_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M300987200"},{"key":"e_1_2_6_65_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0706218"},{"key":"e_1_2_6_66_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.63.3.699"},{"key":"e_1_2_6_67_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.1998.274.1.H375"},{"key":"e_1_2_6_68_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M011055200"},{"key":"e_1_2_6_69_1","doi-asserted-by":"publisher","DOI":"10.1054\/plef.2001.0348"},{"key":"e_1_2_6_70_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm960752x"},{"key":"e_1_2_6_71_1","first-page":"931","article-title":"Enzymatic synthesis of oleamide (cis\u20109,10\u2010octadecenoamide), an endogenous sleep\u2010inducing lipid, by rat brain microsomes","volume":"40","author":"Sugiura T","year":"1996","journal-title":"Biochem Mol Biol Int"},{"key":"e_1_2_6_72_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.25.14115"},{"key":"e_1_2_6_73_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1998.tb10190.x"},{"key":"e_1_2_6_74_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4547(19971215)50:6<1047::AID-JNR16>3.0.CO;2-1"},{"key":"e_1_2_6_75_1","doi-asserted-by":"publisher","DOI":"10.2174\/1381612054546914"},{"key":"e_1_2_6_76_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.105.095059"},{"key":"e_1_2_6_77_1","doi-asserted-by":"publisher","DOI":"10.1038\/376590a0"},{"key":"e_1_2_6_78_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0703051"},{"key":"e_1_2_6_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-3084(02)00152-4"},{"key":"e_1_2_6_80_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0701546"},{"key":"e_1_2_6_81_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0702111"},{"key":"e_1_2_6_82_1","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0022-3565(24)36812-0","article-title":"The biodisposition and metabolism of anandamide in mice","volume":"282","author":"Willoughby KA","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_6_83_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000539-199806000-00031"},{"key":"e_1_2_6_84_1","doi-asserted-by":"publisher","DOI":"10.1038\/22761"}],"container-title":["Cardiovascular Drug Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1527-3466.2007.00004.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1527-3466.2007.00004.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T15:48:28Z","timestamp":1740412108000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1527-3466.2007.00004.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":83,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["10.1111\/j.1527-3466.2007.00004.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1527-3466.2007.00004.x","archive":["Portico"],"relation":{},"ISSN":["0897-5957","1527-3466"],"issn-type":[{"value":"0897-5957","type":"print"},{"value":"1527-3466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}